The nutritional, cardiovascular and immunological effect of daily subcutaneous ghrelin in dialysis patients with evidence of malnutrition

ISRCTN ISRCTN43319045
DOI https://doi.org/10.1186/ISRCTN43319045
Secondary identifying numbers N/A
Submission date
06/03/2006
Registration date
22/06/2006
Last edited
20/01/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Peter Choi
Scientific

West London Renal and Transplant Centre
Hammersmith Hospital
Du Cane Road
London
W12 0HS
United Kingdom

Study information

Study designRandomised, double-blind, placebo-controlled, crossover trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study objectivesGhrelin treatment has beneficial effects on the disordered nutritional, cardiovascular and immunological physiology of dialysis patients.
Ethics approval(s)Approved by the Riverside Research Ethics Committee on 01/02/2006, reference number: 05/Q0401/132
Health condition(s) or problem(s) studiedMalnutrition or renal failure
InterventionSubcutaneous ghrelin versus placebo
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Ghrelin
Primary outcome measure1. Blood pressure
2. Energy expenditure
3. Cytokine production
Secondary outcome measures1. Food intake
2. Nutritional parameters
Overall study start date13/03/2006
Completion date01/12/2006

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants20
Key inclusion criteriaDialysis patients at West London Renal and Transplant Centre, Hammersmith Hospital with evidence of malnutrition
Key exclusion criteria1. Anaemia
2. Over 75 years of age
3. Recent illness
Date of first enrolment13/03/2006
Date of final enrolment01/12/2006

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

West London Renal and Transplant Centre
London
W12 0HS
United Kingdom

Sponsor information

Hammersmith Hospitals NHS Trust (UK)
Hospital/treatment centre

Du Cane Road
London
W12 0HS
England
United Kingdom

Website http://www.hhnt.org/trust/index.htm
ROR logo "ROR" https://ror.org/05jg8yp15

Funders

Funder type

Government

Hammersmith Hospital NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/07/2009 Yes No